A Long-term Extension Clinical Study of TLL-018 in Patients With Rheumatoid Arthritis

Summary

The primary objective of the study is to evaluate the long-term safety, tolerability, and efficacy of TLL-018 in patients with rheumatoid arthritis (RA) who have completed a preceding randomized controlled trial with TLL-018.

Timeline

Start

2025-03-10

Primary completion

2026-12-31

Completion

2027-12-31

Drugs

Indications